Novo Nordisk Sues New Jersey Firm Over Unauthorized Generic Versions of Ozempic and Wegovy

A New Jersey company has allegedly violated trademark and false advertising laws by marketing drugs that purportedly serve as generic versions of Novo Nordisk’s Ozempic and Wegovy medications without obtaining regulatory approval. The Danish pharmaceutical company has filed a lawsuit in a New Jersey federal court, asserting that these actions mislead consumers and infringe upon Novo Nordisk’s trademark rights. For more detailed information, read the original article.